Artículos por temáticas

Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders.

Sharma S, Kumar K, Deshmukh R, Sharma PL.

Eur J Pharmacol. 2013 Aug 15;714(1-3):486-97. doi: 10.1016/j.ejphar.2013.06.038. Review.

Very early pattern of movement disorders in sepiapterin reductase deficiency.

Leuzzi V, Carducci C, Tolve M, Giannini MT, Angeloni A, Carducci C.

Neurology. 2013 Dec 10;81(24):2141-2. doi: 10.1212/01.wnl.0000437299.51312.5f. No abstract available.

[Genetics of movement disorders].

Lohmann K, Brockmann K.

Nervenarzt. 2013 Feb;84(2):143-50. doi: 10.1007/s00115-012-3638-y. Review. German.

Clinical neurophysiology in movement disorders.

Apartis E.

Handb Clin Neurol. 2013;111:87-92. doi: 10.1016/B978-0-444-52891-9.00008-7. Review.

[Development of movement disorders in DBA/2J male mice under repeated experience of aggression].

Vishnivetskaia GB, Avgustinovich DF, Kudriavtseva NN.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2013 Mar-Apr;63(2):235-45. Russian.

Movement disorders: novel FUS gene variants linked to essential tremor.

Wood H.

Nat Rev Neurol. 2013 Aug;9(8):418. doi: 10.1038/nrneurol.2013.143. No abstract available.

Interdisziplinärer Arbeitskreis Bewegungsstörungen (IAB): an interdisciplinary working group for promoting multimodal therapy of movement disorders.

Adib Saberi F, Dressler D.

J Neural Transm (Vienna). 2013 Apr;120(4):705-10. doi: 10.1007/s00702-012-0932-6. Review.

[Clinical treatment of spasticity--spastic movement disorders].

Dietz V.

Nervenarzt. 2013 Dec;84(12):1508-11. doi: 10.1007/s00115-013-3933-2. Review. German.

Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders.

Garcin B, Roze E, Mesrati F, Cognat E, Fournier E, Vidailhet M, Degos B.

J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):1043-6. doi: 10.1136/jnnp-2012-304062.

Clozapine and tardive movement disorders: a review.

Hazari N, Kate N, Grover S.

Asian J Psychiatr. 2013 Dec;6(6):439-51. doi: 10.1016/j.ajp.2013.08.067. Review.

Movement disorders in adult patients with classical galactosemia.

Rubio-Agusti I, Carecchio M, Bhatia KP, Kojovic M, Parees I, Chandrashekar HS, Footitt EJ, Burke D, Edwards MJ, Lachmann RH, Murphy E.

Mov Disord. 2013 Jun;28(6):804-10. doi: 10.1002/mds.25348.

Immune-mediated extrapyramidal movement disorders, including Sydenham chorea.

Dale RC.

Handb Clin Neurol. 2013;112:1235-41. doi: 10.1016/B978-0-444-52910-7.00046-5. Review.

Diagnosis and treatment of impulse control disorders in patients with movement disorders.

Mestre TA, Strafella AP, Thomsen T, Voon V, Miyasaki J.

Ther Adv Neurol Disord. 2013 May;6(3):175-88. doi: 10.1177/1756285613476127.

Binocular vision and eye movement disorders in older adults.

Leat SJ, Chan LL, Maharaj PD, Hrynchak PK, Mittelstaedt A, Machan CM, Irving EL.

Invest Ophthalmol Vis Sci. 2013 May 31;54(5):3798-805. doi: 10.1167/iovs.12-11582.

Unusual movement disorders in spinocerebellar ataxias.

Pedroso JL, Carvalho AA, Escorcio Bezerra ML, Braga-Neto P, Abrahão A, Albuquerque MV, Saraiva-Pereira ML, Jardim LB, Cardoso F, Barsottini OG.

Parkinsonism Relat Disord. 2013 Sep;19(9):834-5. doi: 10.1016/j.parkreldis.2013.04.012. No abstract available.